136 related articles for article (PubMed ID: 14989386)
1. Unanswered questions on omalizumab (Xolair) patient selection and follow-up.
Lanier B; Marshall GD
Ann Allergy Asthma Immunol; 2004 Feb; 92(2):198-200. PubMed ID: 14989386
[No Abstract] [Full Text] [Related]
2. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
Michils A; Sternon J
J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: an open-label study.
Niven R; Chung KF; Panahloo Z; Blogg M; Ayre G
Respir Med; 2008 Oct; 102(10):1371-8. PubMed ID: 18657960
[TBL] [Abstract][Full Text] [Related]
4. Omalizumab for asthma.
Strunk RC; Bloomberg GR
N Engl J Med; 2006 Jun; 354(25):2689-95. PubMed ID: 16790701
[No Abstract] [Full Text] [Related]
5. Home therapy with subcutaneous anti-immunoglobulin-E antibody omalizumab in 25 patients with immunoglobulin-E-mediated (allergic) asthma.
Liebhaber M; Dyer Z
J Asthma; 2007 Apr; 44(3):195-6. PubMed ID: 17454337
[No Abstract] [Full Text] [Related]
6. After 6 years with Xolair; a 3-year withdrawal follow-up.
Nopp A; Johansson SG; Adédoyin J; Ankerst J; Palmqvist M; Oman H
Allergy; 2010 Jan; 65(1):56-60. PubMed ID: 19796193
[TBL] [Abstract][Full Text] [Related]
7. Omalizumab as add-on therapy to inhaled steroids for asthma.
Hadj Tahar A
Issues Emerg Health Technol; 2004 Jun; (58):1-4. PubMed ID: 15455487
[TBL] [Abstract][Full Text] [Related]
8. Intubation secondary to asthma exacerbation in a patient with asthma receiving Xolair (omalizumab).
Jacobs ZD; Guajardo JR
Pediatr Pulmonol; 2008 Jan; 43(1):102-3. PubMed ID: 18041749
[No Abstract] [Full Text] [Related]
9. Omalizumab for asthma.
Winchester DE; Jacob A; Murphy T
N Engl J Med; 2006 Sep; 355(12):1281-2. PubMed ID: 16990394
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
Ayres JG; Higgins B; Chilvers ER; Ayre G; Blogg M; Fox H
Allergy; 2004 Jul; 59(7):701-8. PubMed ID: 15180756
[TBL] [Abstract][Full Text] [Related]
11. Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment.
Ruppert AM; Averous G; Stanciu D; Deroide N; Riehm S; Poindron V; Pauli G; Debry C; de Blay F
J Allergy Clin Immunol; 2008 Jan; 121(1):253-4. PubMed ID: 18206510
[No Abstract] [Full Text] [Related]
12. The beneficial effects of Xolair (omalizumab) as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available treatment (GINA 2002 step IV)--the Israeli arm of the INNOVATE study.
Sthoeger ZM; Eliraz A; Asher I; Berkman N; Elbirt D
Isr Med Assoc J; 2007 Jun; 9(6):472-5. PubMed ID: 17642399
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K
Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
Busse W; Corren J; Lanier BQ; McAlary M; Fowler-Taylor A; Cioppa GD; van As A; Gupta N
J Allergy Clin Immunol; 2001 Aug; 108(2):184-90. PubMed ID: 11496232
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab in children: a negative risk-benefit balance in severe persistent asthma.
Prescrire Int; 2011 Apr; 20(115):92. PubMed ID: 21648208
[No Abstract] [Full Text] [Related]
16. [Omalizumab (Xolair). Product description].
Laursen LC
Ugeskr Laeger; 2007 Mar; 169(11):993-5. PubMed ID: 17371630
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab for asthma.
Tonnel AB; Tillie-Leblond I
N Engl J Med; 2006 Sep; 355(12):1282. PubMed ID: 16998966
[No Abstract] [Full Text] [Related]
18. Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma.
Korn S; Schumann C; Kropf C; Stoiber K; Thielen A; Taube C; Buhl R
Ann Allergy Asthma Immunol; 2010 Oct; 105(4):313-9. PubMed ID: 20934632
[TBL] [Abstract][Full Text] [Related]
19. [Omalizumab. A monoclonal antibody against IgE].
Hennemann A
Med Monatsschr Pharm; 2004 Dec; 27(12):404-7. PubMed ID: 15646688
[No Abstract] [Full Text] [Related]
20. Allergy, Allergic Inflammation and Asthma--Keystone Symposium. Pharmacological targets in allergic inflammation and asthma.
Kierstein S
IDrugs; 2006 Jun; 9(6):405-8. PubMed ID: 16752308
[No Abstract] [Full Text] [Related]
[Next] [New Search]
